A new study finds how Houston — and other Texas cities — rank in terms of the pay gap between male and female workers. Photo via Getty Images

Pi wasn't the only thing celebrated yesterday on March 14. Equal Pay Day is also celebrated on the same day — a day to examine the decades of advocacy to extinguish the pay gap between men and women.

Unfortunately, nationwide the gap is still large. The latest Census Bureau says women make 18 percent less money than men do. We know the numbers for Texas and several of its cities, thanks to a new study by small biz experts Chamber of Commerce. They investigated the earnings for full-time workers in 170 of the most populous cities in the United States.

The analysis found that Texas has the 29th largest pay gap out of all 50 states, with women making nearly $11,000 less than men. Texas women can be glad they don’t live in Wyoming, which has the largest pay gap of the states at almost $19,000.

The city with the largest gender pay gap in the United States is Sunnyvale, California, home to Silicon Valley, with an earnings difference of $40,584 between men and women. Actually, California cities make up half of the top 10 largest gender pay gaps.

Texas, however, has two towns in the top 10. Coming in at No. 2 is Frisco and McKinney lands at No. 5. Frisco men make nearly $40,000 more than women, while McKinney men make $29,000 more than women. Just outside the top 10 is Plano at No. 12, with their gender pay gap adding up to $20,736.

How does Houston fair? Not too shabby, actually. The Bayou City landed at the No. 114 spot out of 170 of the most-populated cities in the U.S. Dallas actually has the smallest gender pay gap in Texas, coming in at No. 166 with just $192 between full-time working men and women.

Here's how the rest of Texas ranks:

  • No. 13 – Austin
  • No. 25 – Pasadena
  • No. 30 – Lubbock
  • No. 45 – Fort Worth
  • No. 70 – Irving
  • No. 71 – Corpus Christi
  • No. 74 – San Antonio
  • No. 89 – Arlington
  • No. 93 – Grand Prairie
  • No 97 – El Paso
  • No. 101 – Laredo
  • No. 110 – Amarillo
  • No. 125 – Brownsville
  • No. 134 – Garland

The full study can be found on chamberofcommerce.org.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”